A 52-wk Prospective, Randomized, Double-blind, Multicenter Study of Relapse Following Transition From Oral Antipsychotic Medication to 2 Different Doses (25 or 50 mg Every 2 Wks) of Risperidone Long-acting Microspheres (Risperdal� CONSTA�) in Adults With Schizophrenia or Schizoaffective Disorder
收藏DataCite Commons2025-01-29 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004707/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess the time for patients to relapse when switched from an oral antipsychotic to one of two doses of long-acting risperidone injection (shots). Risperidone has been used successfully to treat schizophrenia and schizoaffective disorder.
提供机构：
Vivli
创建时间：
2019-09-19
